Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)(86261-44-1)
- Name: Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)
- Synonyms:Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)
- Molecular Formula:C9H15NO
- Molecular Weight:0
- CAS Registry Number:86261-44-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.86261-44-1 Morpholine,4-(1-ethyl-2-propynyl)- (9CI)
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.86261-44-1 Morpholine,4-(1-ethyl-2-propynyl)- (9CI)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.86261-44-1 Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 146300-22-3/2,5-Pyrrolidinedione, 1-(1,3-benzodioxol-5-yl)-
- 1125593-20-5/1-(4-(4-(2-(isopropylsulfonyl)phenylamino)-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol
- 1262036-50-9/LY2886721
- 1331773-19-3/Pyridine, 2-(2,5-dibromo-3-thienyl)-6-hexyl-
- 1283519-40-3/KN-92
- 1331773-18-2/Pyridine, 2-hexyl-6-(3-thienyl)-
- 660847-06-3/HDAC inhibitor
- 918659-56-0/Chaetominine
- 1258861-20-9/LY2940680
- 1124329-14-1/9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one
- 209984-56-5/DIBENZAZEPINE
- 1234703-40-2/LY-2608204
- 1138549-36-6/CX-5461
- 1227923-29-6/3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one
- 1220510-45-1/N1-[(6S,10S)-6-Ethyl-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethylethanediamide
- 435345-47-4/Pyridinium, 3,5-bis(aminocarbonyl)-1-(phenylmethyl)-, bromide (1:1)
- 1315513-10-0/Phosphine oxide, (2,2-diethoxyethyl)bis(4-methylphenyl)-
- 552883-91-7/4-(3-FLUORO-4-NITROBENZYL)MORPHOLINE
- 505052-64-2/4-(5-BROMO-3-NITRO-PYRIDIN-2-YL)-MORPHOLINE
- 86261-44-1/Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)
- 150047-50-0/(E)-OCTADEC-2-EN-13-YN-1-OL
- 187806-17-3/[(E)-5-Acetoxypent-3-enyl] acetate
- 892654-56-7/GGTI-DU40
- 765317-72-4/3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]-6-benzofuransulfonamide
- 221205-90-9/N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
- 283159-90-0/valiphenal
- 394730-71-3/1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(difluoromethyl)sulfanyl]-5-[(pyridin-2-ylmethyl)amino]-1H-pyrazole-3-carbonitrile
- 447399-55-5/3-({[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole
- 315208-17-4/1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(fluoromethyl)sulfanyl]-5-[(pyrazin-2-ylmethyl)amino]-1H-pyrazole-3-carbonitrile
- 140163-89-9/O-ethyl S-propyl [(2E)-2-(cyanoimino)-3-ethylimidazolidin-1-yl]phosphonothioate